Advertisement

Virus Interactions with the Host: Past, Present and Future Developments

  • John J. Trentin
Part of the University of South Florida International Biomedical Symposia Series book series (USFIBSS)

Abstract

The first demonstration of the oncogenicity of a human virus was the induction of malignant transplantable tumors by injection of human adenovirus Type 12 into newborn hamsters (1), or mice (2). Tumors arose early at any of several sites of injection, and sometimes remotely, usually in the liver, resulting in death from tumor growth in from 29 to 108 days (3). The tumors were histologically undifferentiated malignant neoplasms (4). They contained virus-induced transplantation antigens (5) and newborn hamsters could be passively protected against tumor induction by immunization of the mothers before pregnancy (6).

Keywords

Acquire Immune Deficiency Syndrome Herpes Virus Adenovirus Type Arterial Smooth Muscle Cell Human Adenovirus 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    J. J. Trentin, Y. Yabe, and G. Taylor, The quest for human cancer viruses. A new approach to an old problem reveals cancer induction in hamsters by human adenovirus, Sci. 137: 835 (1962).CrossRefGoogle Scholar
  2. 2.
    Y. Yabe, L. Samper, E. Bryan, G. Taylor, and J. J. Trentin, Oncogenic effect of human adenovirus, type 12, in mice, Sci 143: 46 (1964).CrossRefGoogle Scholar
  3. 3.
    Y. Yabe, L. Samper, G. Taylor, and J. J. Trentin, Cancer induction in hamsters by human type 12 adenovirus. Effect of route of injection, Proc. Soc. Exp. Biol. Med. 113: 221 (1963).PubMedGoogle Scholar
  4. 4.
    H. J. Spjut, G. L. Van Hoosier, Jr., and J. J. Trentin, Neoplasms in hamsters induced by adenovirus type 12, Arch. Pathol. 83: 199 (1967).Google Scholar
  5. 5.
    J. J. Trentin and E. Bryan, Virus-induced transplantation immunity to human adenovirus type 12 tumors of the hamster and mouse, Proc. Soc. Exp. Biol. Med. 121: 1216 (1966).PubMedGoogle Scholar
  6. 6.
    J. J. Trentin, Immunization against tumors induced by human adenovirus, in: “Viruses Inducing Cancer,” Walter J. Burdette, ed., University of Utah Press (1966).Google Scholar
  7. 7.
    J. J. Trentin, G. L. Van Hoosier, Jr., and L. Samper, The oncogenicity of human adenoviruses in hamsters, Proc. Soc. Exp. Biol. Med. 127: 683 (1968).PubMedGoogle Scholar
  8. 8.
    R. J. Heubner, W. P. Row, and W. T. Lane, Oncogenic effects in hamsters of human adenovirus Type 12 and 18, Proc. Natl. Acad. Sci. U.S. 48: 2051 (1962).CrossRefGoogle Scholar
  9. 9.
    A. J. Girardi, M. R. Hilleman, and R. E. Zwickey, Tests in hamsters for oncogenic quality of ordinary viruses including adenovirus Type 7, Proc. Soc. Exp. Biol. Med. 115: 1141 (1964).PubMedGoogle Scholar
  10. 10.
    M. S. Pereira, H. G. Pereira, and S. K. R. Clarke, Human adenovirus Type 31. A new serotype with oncogenic properties, Lancet 1: 21 (1965).PubMedCrossRefGoogle Scholar
  11. 11.
    R. J. Huebner, J. J. Casey, R. M. Chanock, and K. Scholl, Tumors induced in hamsters by a strain of adenovirus Type 3: sharing of tumor antigens and “neoantigens” with those produced by adenovirus Type 7 tumors, Proc. Natl. Acad. Sci. U.S. 54: 381 (1965).CrossRefGoogle Scholar
  12. 12.
    K. Fujinaga and M. Green, The mechanism of viral carcinogenesis by DNA mammalian viruses: Viral-specific RNA in polyribosomes of adenovirus tumor and transformed cells, Proc. Natl. Acad. Sci. U.S. 55: 1567 (1966).CrossRefGoogle Scholar
  13. 13.
    M. D. Hoggan, W. P. Rowe, P. H. Black, and R. J. Huebner, Production of “tumor-specific” antigens by oncogenic viruses during acute cytolytic infections, Proc. Natl. Acad. Sci. U.S. 53: 12 (1965).CrossRefGoogle Scholar
  14. 14.
    G. L. Van Hoosier, Jr., S. Stinebaugh, and J. J. Trentin, CF reactions with human adenovirus type 12 (A-12) hamster and mouse tumors and observations on human sera and tumors, Fed. Proc. 23: 130 (1964).Google Scholar
  15. 15.
    J. H. Pope and W. P. Rowe, Immunofluorescent studies of adenovirus 12 tumors and of cells transformed or infected by adenoviruses, J. Exptl. Med. 120: 577 (1964).CrossRefGoogle Scholar
  16. 16.
    J. D. Levinthal, C. Ahmad-Zadeh, G. L. Van Hoosier, Jr., and J. J. Trentin, Immunofluorescence of human adenovirus type 12 in various cell types, Proc. Soc. Exp. Biol. Med. 121: 405 (1966).PubMedGoogle Scholar
  17. 17.
    L. D. Berman and W. P. Rowe, A study of the antigens involved in adenovirus 12 tumorigenesis by immunodiffusion techniques, J. Exptl. Med. 121: 955 (1965).CrossRefGoogle Scholar
  18. 18.
    R. B. Herberman and J. R. Ortaldo, Natural killer cells: their role in defense against disease, Science 214: 24 (1981).PubMedCrossRefGoogle Scholar
  19. 19.
    J. L. Cook, J. Hauser, C. T. Patch, A. M. Lewis, Jr., and A. S. Levine, Adenovirus 2 early gene expression promotes susceptibility to effector cell lysis of hybrids formed between hamster cells transformed by adenovirus 2 and simian virus 40, Proc. Natl. Acad. Sci. U.S. 80: 5995 (1983).CrossRefGoogle Scholar
  20. 20.
    J. L. Cook and A. M. Lewis, Jr., Differential NK cell and macrophage killing of hamster cells infected with non-oncogenic or oncogenic adenovirus, Science 124: 612 (1984).CrossRefGoogle Scholar
  21. 21.
    J. M. Sheil, P. H. Gallimore, S. G. Zimmer, and M. L. Sopori, Susceptibility of adenovirus 2-transformed rat cell lines to natural killer (NK) cells: direct correlation between NK resistance and in vivo tumorigenesis, J. Immunol. 132: 1578 (1984).PubMedGoogle Scholar
  22. 22.
    G. L. Van Hoosier, Jr. and J. J. Trentin, Reactivity of human sera with adenovirus type-12 hamster tumor antigens in the complement-fixation test, J. Natl. Cancer Inst. 40: 249 (1968).PubMedGoogle Scholar
  23. 23.
    K. J. McCormick, G. L. Van Hoosier, Jr., and J. J. Trentin, Attempts to find human adenovirus type-12 tumor antigens in human tumors, J. Natl. Cancer Inst. 40: 255 (1968).PubMedGoogle Scholar
  24. 24.
    M. Green and W. S. M. Wold, Search for adenovirus genetic information in normal and malignant human tissues, in: “Viruses Associated with Human Cancer,” L. A. Phillips, ed., Marcel Dekker, Inc., New York (1983).Google Scholar
  25. 25.
    J. H. Darbyshire, Oncogenicity of bovine adenovirus Type 3 in hamsters, Nature 211: 102 (1966).PubMedCrossRefGoogle Scholar
  26. 26.
    P. S. Sarma, R. J. Huebner, and W. T. Lane, Induction of tumors in hamsters with an avian adenovirus (CELO), Science 149: 1108 (1965).PubMedCrossRefGoogle Scholar
  27. 27.
    R. N. Hull, I. S. Johnson, C. G. Culbertson, C. B. Reimer, and H. F. Wright, Oncogenicity of the simian adenoviruses, Science 150: 1044 (1965).PubMedCrossRefGoogle Scholar
  28. 28.
    K. Ogawa, A. Tsutsumi, K. Iwata, Y. Fujii, M. Okmori, K. Taguchi, and Y. Yabe, Histogenesis of malignant neoplasms induced by adenovirus type 12, Gann 57: 43 (1966).PubMedGoogle Scholar
  29. 29.
    K. Ogawa, K. Hamaya, Y. Fujii, K. Matsuura, and T. Endo, Tumor induction by adenovirus Type 12 and its target cells in the central nervous system, Gann 60: 3837.Google Scholar
  30. 30.
    D. M. Albert, A. S. Rabson, and A. J. Dalton, In vitro neoplastic transformation of uveal and retinal tissue by oncogenic DNA viruses, Invest. Ophthalmol. 7:357 (1968).Google Scholar
  31. 31.
    S. Kobayashi and M. Mukai, Retinoblastoma-like tumors induced by human adenovirus Type 12 in rats, Cancer Res. 34: 1646 (1974).PubMedGoogle Scholar
  32. 32.
    N. Mukai, S. S. Kalter, L. B. Cummins, V. A. Matthews, T. Nishida, and T. Nakajima, Retinal tumor induced in the baboon by human adenovirus 12, Science 210: 1023 (1980).PubMedCrossRefGoogle Scholar
  33. 33.
    T. Byrd, K. W. Brown, and P. H. Gallimore, Malignant transformation of human embryo retinoblasts by cloned adenovirus 12 DNA, Nature 298: 69 (1982).PubMedCrossRefGoogle Scholar
  34. 34.
    S. Mak, I. Mak, B. L. Gallie, R. Godbout., and R. A. Phillips, Adenovirus-12 genes undetectable in human retinoblastoma, Int. Cancer 30: 697 (1982).CrossRefGoogle Scholar
  35. 35.
    H. Ibelgaufts, K. W. Jones, N. Maitland, and J. F. Shaw, Adenovirus-related RNA sequences in human neurogenic tumors, Acta. Neuropathol. (Berlin) 56: 113 (1982).Google Scholar
  36. 36.
    R. Ross and J. A. Glomset, Atherosclerosis and the arterial smooth muscle cell. Proliferation of smooth muscle is a key event in the genesis of the lesions of atherosclerosis, Science 180: 1332 (1973).PubMedCrossRefGoogle Scholar
  37. 37.
    P. J. Fialkow, The origin and development of human tumors studied with cell markers, New Eng. J. Med. 291: 26 (1974).PubMedCrossRefGoogle Scholar
  38. 38.
    D. Lindner and S. M. Gartler, Glucose-6-phosphate dehydrogenase mosaicism: utilization as a cell marker in the study of leiomyomas, Science 150: 67 (1965).CrossRefGoogle Scholar
  39. 39.
    E. P. Benditt and J. M. Benditt, Evidence for a monoclonal origin of human atherosclerotic plaques, Proc. Natl. Acad. Sci. U.S. 70: 1753 (1973).CrossRefGoogle Scholar
  40. 40.
    T. A. Pearson, A. Wang, K. Solez, and R. H. Heptinstall, Clonal characteristics of fibrous plaques and fatty streaks from human aortas, Amer. J. Pathol. 81: 379 (1975).Google Scholar
  41. 41.
    J. C. Paterson and G. E. Cottral, Experimental coronary sclerosis. Ill Lymphomatosis as a cause of coronary sclerosis in chicken, Arch. Pathol. 49: 699 (1950).Google Scholar
  42. 42.
    R. E. Albert, M. Vanderlaan, F. J. Burns, and M. Nishizumi, Effect of carcinogens on chicken atherosclerosis, Cancer Res. 37: 2232 (1977).PubMedGoogle Scholar
  43. 43.
    C. G. Fabricant, J. Fabricant, M. M. Litrenta, and C. R. Minick, Virus-induced atherosclerosis, J. Exp. Med. 148: 335 (1978).PubMedCrossRefGoogle Scholar
  44. 44.
    C. R. Minick, C. G. Fabricant, J. Fabricant, and M. M. Litrenta, Atherosclerosis induced by infection with a herpesvirus, J. Amer. Pathol. 96: 673 (1979).Google Scholar
  45. 45.
    J. D. Morrisett, H. S. Kim, J. R. Patsch, S. K. Datta, and J. J. Trentin, Genetic susceptibility and resistance to diet-induced atherosclerosis and hyperlipoproteinemia, Artheriosclerosis 2: 312 (1982).CrossRefGoogle Scholar
  46. 46.
    E. P. Benditt, The origin of atherosclerosis, Scientific American 236:#2, 74 (1977).Google Scholar
  47. 47.
    W. L. Kos, R. M. Loria, M. J. Snodgrass, D. Cohen, T. G. Thorpe, and A. M. Kaplan, Inhibition of host resistance by nutritional hypercholesteremia, Infection and Immunity 26: 658 (1979).PubMedGoogle Scholar
  48. 48.
    C. G. Fabricant, D. P. Hajjar, and C. R. Minick, Herpesvirus infection enhances cholesterol and cholesteryl ester accumulation in cultured arterial smooth muscle cells. Amer. Pathol. 105: 176 (1981).Google Scholar
  49. 49.
    J. L. Melnick, G. R. Dressman, C. H. McCollum, B. L. Petrie, J. Burek, and M. E. DeBakey, Cytomegalovirus antigen within human arterial smooth muscle cells, Lancet, Sept. 17 (1983).Google Scholar
  50. 50.
    E. P. Benditt, T. Barrett, and J. T. McDougall, Viruses in the etiology of atherosclerosiss Proc. Nat. Acad. Sci. 80: 6386 (1983).PubMedCrossRefGoogle Scholar
  51. 51.
    J. J. Tumilowicz, G. E. Gallick, J. L. East, J. J. Trentin, and R. B. Arlinghaus, Presence of retrovirus in the B95-8 Epstein-Barr virus-producing cell line from different sources, In Vitro 20: 486 (1984).PubMedCrossRefGoogle Scholar
  52. 52.
    M. Popovic, V. S. Kalyanaraman, M. S. Reitz, M. G. Sarngadharan, Identification of the RPMI 8226 retrovirus and its dissemination as a significant contaminant of some widely used human and marmoset cell lines, Int. J. Cancer 30: 93 (1982).PubMedCrossRefGoogle Scholar
  53. 53.
    M. R. Rilleman, Vaccines for the decade of the 1980Ts and beyond, S. Afr. Med. Jour. 61: 691 (1982).Google Scholar
  54. 54.
    J. J. Trentin, Tumor immunotherapy in experimental animals: current status and prospectus, Annals N.Y. Acad. Sci. 227: 716 (1976).CrossRefGoogle Scholar
  55. 55.
    Multiple authors and articles, in: “Avian Diseases; Special Issue; Control of Marek’s Disease,” Vol. 16, No. 1, pp. 1-200 (1972).Google Scholar
  56. 56.
    C. G. Fabricant, J. Fabricant, C. R. Minick, and M. M. Litrenta, Herpesvirus-induced atherosclerosis in chickens, Fed. Proc. 42: 2476 (1983).PubMedGoogle Scholar

Copyright information

© Plenum Press, New York 1986

Authors and Affiliations

  • John J. Trentin
    • 1
  1. 1.Division of Experimental BiologyBaylor College of MedicineHoustonUSA

Personalised recommendations